NO974514D0 - Syntetisk HPV6/11 hydrud L1 DNA som koder for humant papillomavirus Type 11 L1-protein - Google Patents

Syntetisk HPV6/11 hydrud L1 DNA som koder for humant papillomavirus Type 11 L1-protein

Info

Publication number
NO974514D0
NO974514D0 NO974514A NO974514A NO974514D0 NO 974514 D0 NO974514 D0 NO 974514D0 NO 974514 A NO974514 A NO 974514A NO 974514 A NO974514 A NO 974514A NO 974514 D0 NO974514 D0 NO 974514D0
Authority
NO
Norway
Prior art keywords
protein
human papillomavirus
synthetic
hpv6
hydride
Prior art date
Application number
NO974514A
Other languages
English (en)
Other versions
NO320086B1 (no
NO974514L (no
Inventor
Kathryn J Hofmann
Kathrin U Jansen
Michael P Neeper
Joseph G Joyce
Hugh A George
Ernest Dale Lehman
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27022236&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO974514(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of NO974514D0 publication Critical patent/NO974514D0/no
Publication of NO974514L publication Critical patent/NO974514L/no
Publication of NO320086B1 publication Critical patent/NO320086B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO19974514A 1995-03-30 1997-09-29 Nukleinsyremolekyl som koder for humant papillomavirus type 11 L1-protein, ekspresjonsvektor som omfatter nukleinsyremolekylet, preparat som omfatter nukleinsyremolekylet og anvendelse av det for fremstilling av medikament. NO320086B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41357195A 1995-03-30 1995-03-30
US41357295A 1995-03-30 1995-03-30
PCT/US1996/004117 WO1996030520A2 (en) 1995-03-30 1996-03-26 Synthetic hpv6/11 hybrid l1 dna encoding human papillomavirus type 11 l1 protein

Publications (3)

Publication Number Publication Date
NO974514D0 true NO974514D0 (no) 1997-09-29
NO974514L NO974514L (no) 1997-11-27
NO320086B1 NO320086B1 (no) 2005-10-24

Family

ID=27022236

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19974514A NO320086B1 (no) 1995-03-30 1997-09-29 Nukleinsyremolekyl som koder for humant papillomavirus type 11 L1-protein, ekspresjonsvektor som omfatter nukleinsyremolekylet, preparat som omfatter nukleinsyremolekylet og anvendelse av det for fremstilling av medikament.

Country Status (21)

Country Link
US (1) US6159729A (no)
EP (1) EP0817852B1 (no)
JP (1) JP3918877B2 (no)
KR (1) KR100441477B1 (no)
CN (1) CN1154732C (no)
AT (1) ATE247712T1 (no)
AU (1) AU708111B2 (no)
CZ (1) CZ291375B6 (no)
DE (1) DE69629556T2 (no)
DK (1) DK0817852T3 (no)
EA (1) EA000969B1 (no)
ES (1) ES2203691T3 (no)
HU (1) HU228490B1 (no)
IL (1) IL117591A0 (no)
NO (1) NO320086B1 (no)
NZ (1) NZ306663A (no)
PL (1) PL183299B1 (no)
PT (1) PT817852E (no)
SK (1) SK283998B6 (no)
WO (1) WO1996030520A2 (no)
ZA (1) ZA962526B (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996009375A1 (en) * 1994-09-22 1996-03-28 Merck & Co., Inc. Dna encoding human papillomavirus type 6a
GB9621091D0 (en) 1996-10-09 1996-11-27 Fondation Pour Le Perfectionem Attenuated microorganisms strains and their uses
EP0973546B1 (en) * 1997-04-08 2004-03-17 Merck & Co., Inc. Stabilized human papillomavirus formulations
IL141130A0 (en) * 1998-08-14 2002-02-10 Merck & Co Inc Process for purifying human papilloma virus-like particles
DE19840263C1 (de) * 1998-09-03 2000-05-25 Deutsches Krebsforsch Papillomviren, Mittel zu deren Nachweis sowie zur Therapie von durch sie verursachten Erkrankungen
US6380364B1 (en) 1998-11-23 2002-04-30 Loyola University Of Chicago Chimeric biotin-binding papillomavirus protein
AUPP765398A0 (en) 1998-12-11 1999-01-14 University Of Queensland, The Treatment of papillomavirus infections
AU764138B2 (en) 1999-02-05 2003-08-14 Merck Sharp & Dohme Corp. Human papilloma virus vaccine formulations
US7001995B1 (en) * 1999-08-25 2006-02-21 Merck & Co., Inc. Synthetic human papillomavirus genes
EP1806410A3 (en) * 2001-08-23 2007-10-24 Merck & Co., Inc. Fluorescent multiplex HPV PCR assays using multiple fluorophores
EP1302550A1 (en) * 2001-10-10 2003-04-16 King Car Food Industrial Co., Ltd. Method and detector for identifying subtypes of human papilloma viruses
BRPI0407877A (pt) * 2003-03-07 2006-03-01 Merck & Co Inc conjugado de peptìdeo-proteìna, vacina para a prevenção ou melhora da infecção pelo vìrus influenza, e, método para induzir um resposta imune em um paciente
KR101080628B1 (ko) 2003-03-24 2011-11-08 머크 샤프 앤드 돔 코포레이션 효모에서 ｈｐｖ 31 ｌ1의 최적 발현
IL156670A0 (en) * 2003-06-26 2004-01-04 Zvi Zolotariov Aloe suppositories
WO2005030041A2 (en) * 2003-09-25 2005-04-07 Third Wave Technologies, Inc. Detection of hpv
MY140664A (en) * 2003-09-29 2010-01-15 Merck Sharp & Dohme Optimized expression of hpv 45 l1 in yeast
MY139500A (en) * 2003-11-12 2009-10-30 Merck Sharp & Dohme Optimized expression of hpv 58 l1 in yeast
PL1730175T3 (pl) * 2004-03-24 2010-09-30 Merck Sharp & Dohme Optymalizowana ekspresja L1 HPV 52 w drożdżach
WO2006063065A2 (en) 2004-12-08 2006-06-15 Gen-Probe Incorporated Detection of nucleic acids from multiple types of human papillomaviruses
ES2524050T3 (es) * 2004-12-10 2014-12-03 Genera Biosystems Limited Detección del virus del papiloma humano (VPH) usando sondas de ácidos nucleicos, microperlas y clasificadores celulares activados por fluorescencia (FACS)
PL1844164T3 (pl) * 2005-11-15 2010-12-31 Genoid Kft Sposób wykrywania patogenów z zastosowaniem sond typu "latarni molekularnych"
US8080643B2 (en) * 2006-09-05 2011-12-20 Third Wave Technologies, Inc. HPV primers
CN101200696B (zh) * 2007-11-14 2011-07-20 山东大学 人乳头瘤病毒的酵母增殖模型及建立方法与应用
KR20090073987A (ko) * 2007-12-31 2009-07-03 정운원 인간유두종바이러스 유전자형 검사를 위한 프라이머, 프로브 및 이를 포함하는 ｄｎａ칩, 이의 검사 방법 및 검사 키트
US9376727B2 (en) 2010-05-25 2016-06-28 Qiagen Gaithersburg, Inc. Fast results hybrid capture assay and associated strategically truncated probes
WO2012065034A1 (en) 2010-11-12 2012-05-18 Merck Sharp & Dohme Corp. Enolase peptide conjugate vaccines against staphylococcus aureus
AU2012270418B2 (en) * 2011-06-15 2015-08-13 Posvax Co., Ltd Method for enhancing the production yield of human papillomavirus L1 protein
US10513541B2 (en) 2015-12-04 2019-12-24 Xiamen University Mutant of L1 protein of human papillomavirus type 11
BR112021005626A2 (pt) * 2018-09-26 2021-06-29 Xiamen University mutante de proteína l1 de papilomavírus humano de tipo 51

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0595935T3 (da) * 1991-07-19 2003-07-21 Csl Ltd Papillomavirusvaccine
ATE492289T1 (de) * 1993-03-09 2011-01-15 Univ Rochester Herstellung von menschlichen papillomavirus hbv- 11 kapsidprotein l1 und virus-ähnliche partikeln

Also Published As

Publication number Publication date
PL183299B1 (pl) 2002-06-28
PL322588A1 (en) 1998-02-02
CN1154732C (zh) 2004-06-23
DE69629556D1 (de) 2003-09-25
EP0817852A2 (en) 1998-01-14
NO320086B1 (no) 2005-10-24
AU708111B2 (en) 1999-07-29
EP0817852B1 (en) 2003-08-20
ES2203691T3 (es) 2004-04-16
CZ291375B6 (cs) 2003-02-12
ZA962526B (en) 1996-09-04
CZ309197A3 (cs) 1998-02-18
KR100441477B1 (ko) 2004-10-06
HU228490B1 (en) 2013-03-28
JPH11503313A (ja) 1999-03-26
US6159729A (en) 2000-12-12
SK283998B6 (sk) 2004-07-07
WO1996030520A2 (en) 1996-10-03
PT817852E (pt) 2003-12-31
EA199700281A1 (ru) 1998-04-30
IL117591A0 (en) 1996-07-23
AU5527796A (en) 1996-10-16
HUP9801608A3 (en) 1999-04-28
DK0817852T3 (da) 2003-11-24
JP3918877B2 (ja) 2007-05-23
HUP9801608A2 (hu) 1998-10-28
ATE247712T1 (de) 2003-09-15
CN1185810A (zh) 1998-06-24
SK129397A3 (en) 1998-05-06
EA000969B1 (ru) 2000-08-28
DE69629556T2 (de) 2004-06-17
WO1996030520A3 (en) 1996-11-07
KR19980703391A (ko) 1998-10-15
NO974514L (no) 1997-11-27
NZ306663A (en) 1999-10-28

Similar Documents

Publication Publication Date Title
NO974514D0 (no) Syntetisk HPV6/11 hydrud L1 DNA som koder for humant papillomavirus Type 11 L1-protein
ATE219064T1 (de) Piperazinderivative als tachykinin antagonisten
DK0675956T3 (da) Nyt protein fra urin betegnet komponent B
AR053946A2 (es) Variante de alfa-amilasa de bacillus stearothermophilus original
NL300273I1 (nl) DNA dat humaan papillomavirus type 18 codeert.
DK0764209T3 (da) Albuminekspression i gær
IL122606A0 (en) (S)-hydroxy-nitrile-lyase
BG101338A (en) Dna encoding human papillomavirus type 6a
ES2143638T3 (es) Bomba de perfusion de liquidos terapeuticos.
ATE161713T1 (de) Feuchtigkeitsspender
DK0891322T3 (da) Dimethylsubstituerede cyclohexandienderivater
FR2759079B1 (fr) Procede de preparation d'anthraquinones substituees et application a la preparation de rheines
SE9501512D0 (sv) Synthetic peptide-defined eptopes useful for vaccination against papillomavirus
IT1275436B (it) Uso della forskolina e di estratti che la contengono per il trattamento della alcol-dipendenza
DE59611353D1 (de) Transketolase-verwandtes protein
ES2191785T3 (es) Proteina de accion antitumoral.
PL322847A1 (en) Condensed b-carbolins

Legal Events

Date Code Title Description
MK1K Patent expired